The classification of glomerulonephritis in systemic lupus erythematosus revisited
- PMID:14747370
- DOI: 10.1097/01.asn.0000108969.21691.5d
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Erratum in
- J Am Soc Nephrol. 2004 Mar;15(3):835-6
Abstract
The currently used classification reflects our understanding of the pathogenesis of the various forms of lupus nephritis, but clinicopathologic studies have revealed the need for improved categorization and terminology. Based on the 1982 classification published under the auspices of the World Health Organization (WHO) and subsequent clinicopathologic data, we propose that class I and II be used for purely mesangial involvement (I, mesangial immune deposits without mesangial hypercellularity; II, mesangial immune deposits with mesangial hypercellularity); class III for focal glomerulonephritis (involving <50% of total number of glomeruli) with subdivisions for active and sclerotic lesions; class IV for diffuse glomerulonephritis (involving > or = 50% of total number of glomeruli) either with segmental (class IV-S) or global (class IV-G) involvement, and also with subdivisions for active and sclerotic lesions; class V for membranous lupus nephritis; and class VI for advanced sclerosing lesions]. Combinations of membranous and proliferative glomerulonephritis (i.e., class III and V or class IV and V) should be reported individually in the diagnostic line. The diagnosis should also include entries for any concomitant vascular or tubulointerstitial lesions. One of the main advantages of the current revised classification is that it provides a clear and unequivocal description of the various lesions and classes of lupus nephritis, allowing a better standardization and lending a basis for further clinicopathologic studies. We hope that this revision, which evolved under the auspices of the International Society of Nephrology and the Renal Pathology Society, will contribute to further advancement of the WHO classification.
Comment on
- Reclassification of lupus glomerulonephritis: back to the future.Glassock RJ.Glassock RJ.J Am Soc Nephrol. 2004 Feb;15(2):501-3. doi: 10.1097/01.asn.0000111982.49602.fe.J Am Soc Nephrol. 2004.PMID:14747399No abstract available.
Similar articles
- The classification of glomerulonephritis in systemic lupus erythematosus revisited.Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis.Weening JJ, et al.Kidney Int. 2004 Feb;65(2):521-30. doi: 10.1111/j.1523-1755.2004.00443.x.Kidney Int. 2004.PMID:14717922Review.
- Morphological parameters in lupus nephritis: their relevance for classification and relationship with clinical and histological findings and outcome.Banfi G, Mazzucco G, Barbiano di Belgiojoso G, Bestetti Bosisio M, Stratta P, Confalonieri R, Ferrario F, Imbasciati E, Monga G.Banfi G, et al.Q J Med. 1985 May;55(217):153-68.Q J Med. 1985.PMID:3159033
- Patterns of renal injury in systemic lupus erythematosus: light and immunofluorescence microscopic observations.Grishman E, Gerber MA, Churg J.Grishman E, et al.Am J Kidney Dis. 1982 Jul;2(1 Suppl 1):135-41.Am J Kidney Dis. 1982.PMID:6213149
- Classification of lupus nephritis.Markowitz GS, D'Agati VD.Markowitz GS, et al.Curr Opin Nephrol Hypertens. 2009 May;18(3):220-5. doi: 10.1097/mnh.0b013e328327b379.Curr Opin Nephrol Hypertens. 2009.PMID:19374008Review.
- Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.Ferluga D, Jerse M, Vizjak A, Hvala A, Rozman B, Kos-Golja M, Bren AF.Ferluga D, et al.Wien Klin Wochenschr. 2000 Aug 25;112(15-16):692-701.Wien Klin Wochenschr. 2000.PMID:11020959
Cited by
- Contribution of Clinically Indicated Repeat Renal Biopsy in Indian Patients with Lupus Nephritis.Gupta KL, Bharati J, Anakutti H, Pattanashetti N, Rathi M, Ramachandran R, Nada R.Gupta KL, et al.Indian J Nephrol. 2020 Nov-Dec;30(6):377-381. doi: 10.4103/ijn.IJN_166_19. Epub 2020 Feb 11.Indian J Nephrol. 2020.PMID:33840956Free PMC article.
- Exposure-effect relationship of mycophenolic acid and prednisolone in adult patients with lupus nephritis.Abd Rahman AN, Tett SE, Abdul Gafor HA, McWhinney BC, Staatz CE.Abd Rahman AN, et al.Br J Clin Pharmacol. 2015 Nov;80(5):1064-75. doi: 10.1111/bcp.12678. Epub 2015 Jul 2.Br J Clin Pharmacol. 2015.PMID:25959850Free PMC article.Clinical Trial.
- Sex differences in patients with systemic lupus erythematosus from Northwest Spain.Alonso MD, Martínez-Vázquez F, Riancho-Zarrabeitia L, Díaz de Terán T, Miranda-Filloy JA, Blanco R, González-Juanatey C, Llorca J, González-Gay MA.Alonso MD, et al.Rheumatol Int. 2014 Jan;34(1):11-24. doi: 10.1007/s00296-013-2798-9. Epub 2013 Jun 28.Rheumatol Int. 2014.PMID:23812032
- The Behaviour of Serum Survivin in Patients With Lupus Nephritis.Lisboa RV, de Oliveira FR, Quaresma TO, de Almeida RM, Ribeiro Oliveira RD, Junior PL.Lisboa RV, et al.Biomark Insights. 2022 Oct 22;17:11772719221131470. doi: 10.1177/11772719221131470. eCollection 2022.Biomark Insights. 2022.PMID:36311208Free PMC article.
- Borrelia and nephropathy: cryoglobulinaemic membranoproliferative glomerulonephritis responsive to doxycyclin in active Lyme disease.Schneider CA, Wiemer J, Seibt-Meisch S, Brückner W, Amann K, Scherberich JE.Schneider CA, et al.Clin Kidney J. 2013 Feb;6(1):77-80. doi: 10.1093/ckj/sfs149. Epub 2012 Nov 8.Clin Kidney J. 2013.PMID:27818755Free PMC article.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical